Total Payments
$2,389
2024 Payments
$520.70
Companies
32
Transactions
135
Medicare Patients
3,844
Medicare Billing
$817,764
Payment Breakdown by Category
Food & Beverage$2,373 (99.3%)
Education$16.01 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,373 | 134 | 99.3% |
| Education | $16.01 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $363.03 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $323.59 | 16 | $0 (2024) |
| Horizon Therapeutics plc | $264.31 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $240.03 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $191.58 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $132.26 | 9 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $89.76 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $83.70 | 4 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $66.90 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $66.62 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $520.70 | 26 | Amgen Inc. ($198.98) |
| 2023 | $491.70 | 26 | Horizon Therapeutics plc ($95.48) |
| 2022 | $409.30 | 25 | Horizon Therapeutics plc ($135.94) |
| 2021 | $253.22 | 16 | AstraZeneca Pharmaceuticals LP ($59.56) |
| 2020 | $31.25 | 2 | Amicus Therapeutics, Inc. ($17.71) |
| 2019 | $284.65 | 16 | Janssen Pharmaceuticals, Inc ($81.18) |
| 2018 | $280.01 | 15 | Otsuka America Pharmaceutical, Inc. ($152.15) |
| 2017 | $118.39 | 9 | Otsuka America Pharmaceutical, Inc. ($39.43) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.35 | General |
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEPHROLOGY | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardio-renal | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Cardio-renal | ||||||
| 06/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/14/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: NEPHROLOGY | ||||||
| 04/15/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $42.50 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: NEPHROLOGY | ||||||
| 04/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/07/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/04/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: NEPHROLOGY | ||||||
| 02/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 793 | 2,240 | $511,317 | $157,215 |
| 2022 | 14 | 970 | 2,971 | $704,844 | $216,049 |
| 2021 | 11 | 942 | 1,992 | $652,441 | $206,969 |
| 2020 | 14 | 1,139 | 2,535 | $698,989 | $237,531 |
Total Patients
3,844
Total Services
9,738
Medicare Billing
$817,764
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 31 | 164 | $148,748 | $44,405 | 29.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 155 | 512 | $92,160 | $31,278 | 33.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 84 | 545 | $54,500 | $24,916 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 192 | 420 | $97,440 | $19,405 | 19.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 75 | $25,575 | $7,532 | 29.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 33 | $24,783 | $7,458 | 30.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 69 | 181 | $17,376 | $6,934 | 39.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 68 | 127 | $8,850 | $4,273 | 48.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 38 | $9,842 | $3,492 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $8,550 | $2,315 | 27.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 50 | $7,895 | $1,703 | 21.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,511 | $1,473 | 26.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 38 | $4,839 | $1,195 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 16 | $5,248 | $837.16 | 16.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 38 | 216 | $195,912 | $59,545 | 30.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 181 | 515 | $133,385 | $40,693 | 30.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 123 | 698 | $69,800 | $31,254 | 44.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 115 | 422 | $75,960 | $23,211 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 196 | 470 | $109,040 | $22,130 | 20.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 72 | 74 | $37,074 | $11,371 | 30.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 23 | 35 | $26,285 | $8,120 | 30.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 106 | 236 | $14,025 | $7,889 | 56.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 28 | $9,548 | $2,926 | 30.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 19 | 61 | $9,632 | $2,533 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 25 | $8,200 | $1,893 | 23.1% |
About Dr. Thaddeo Oconer, MD
Dr. Thaddeo Oconer, MD is a Specialist healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104928571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thaddeo Oconer, MD has received a total of $2,389 in payments from pharmaceutical and medical device companies, with $520.70 received in 2024. These payments were reported across 135 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,373).
As a Medicare-enrolled provider, Oconer has provided services to 3,844 Medicare beneficiaries, totaling 9,738 services with total Medicare billing of $817,764. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Nephrology
- Location Mesa, AZ
- Active Since 09/05/2006
- Last Updated 05/25/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1104928571
Products in Payments
- KRYSTEXXA (Biological) $452.54
- JYNARQUE (Drug) $239.44
- Kerendia (Drug) $191.58
- FARXIGA (Drug) $160.32
- XARELTO (Drug) $132.26
- SAMSCA (Drug) $105.42
- Parsabiv (Biological) $92.84
- ULTOMIRIS (Biological) $89.76
- Auryxia (Drug) $88.02
- Veltassa (Drug) $84.26
- INJECTAFER (Drug) $83.70
- TAVNEOS (Drug) $81.96
- LOKELMA (Drug) $61.54
- ACTHAR (Biological) $46.75
- Crysvita (Drug) $42.50
- LUPKYNIS (Drug) $42.04
- BENLYSTA (Biological) $33.91
- JESDUVROQ (Drug) $32.71
- Rayaldee (Drug) $31.46
- ZEPATIER (Drug) $28.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Mesa
Marc Letellier, Md, MD
Specialist — Payments: $38,429
Specialist $38,429
Ashok Narayan, M.d, M.D
Specialist — Payments: $10,612
Specialist $10,612
Dr. Matthew Karlovsky, Md, MD
Specialist — Payments: $9,539
Specialist $9,539
Dr. Nirain D'souza, M.d, M.D
Specialist — Payments: $4,846
Specialist $4,846
Dr. Andre Matthews, M.d, M.D
Specialist — Payments: $2,944
Specialist $2,944
John Harrison, Md, MD
Specialist — Payments: $1,911
Specialist $1,911